Form 8-K - Current report:
SEC Accession No. 0001104659-21-016781
Filing Date
2021-02-09
Accepted
2021-02-09 17:22:07
Documents
16
Period of Report
2021-02-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm215707d2_8k.htm   iXBRL 8-K 53071
2 EXHIBIT 5.1 tm215707d2_ex5-1.htm EX-5.1 11112
3 EXHIBIT 10.1 tm215707d2_ex10-1.htm EX-10.1 194777
7 GRAPHIC tm215707d2_ex5-1img01.jpg GRAPHIC 11753
8 GRAPHIC image_001.jpg GRAPHIC 11753
  Complete submission text file 0001104659-21-016781.txt   524724

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ocgn-20210207.xsd EX-101.SCH 3196
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocgn-20210207_lab.xml EX-101.LAB 34592
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocgn-20210207_pre.xml EX-101.PRE 22717
9 EXTRACTED XBRL INSTANCE DOCUMENT tm215707d2_8k_htm.xml XML 3485
Mailing Address 5 GREAT VALLEY PARKWAY SUITE 160 MALVERN PA 19355
Business Address 5 GREAT VALLEY PARKWAY SUITE 160 MALVERN PA 19355 484-328-4698
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36751 | Film No.: 21607923
SIC: 2836 Biological Products, (No Diagnostic Substances)